Medco Tops Fortune’s Lists of ‘World’s Most Admired’ Companies
Medco listed No. 1 in Health Care: Pharmacy and Other Services category; No. 5 for innovation and No. 10 for people management worldwide
“To be ranked highest among our industry peers is a great honor that underscores the pioneering spirit of our people in forging a future in healthcare that improves clinical and financial outcomes for our clients and their members,” said Medco Chairman and CEO
Fortune, in partnership with the Hay Group, surveyed more than 650 companies across 64 industry sectors worldwide. To establish the rankings, company executives, board directors and outside analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results are featured in the
According to the Fortune survey, Medco received several industry and global honors:
- No. 1 World’s Most-Admired: “Health Care: Pharmacy and Other Services” category — with the industry’s highest rank in seven attributes: innovation, people management, use of corporate assets, quality of management, financial soundness, quality of products/services and global competitiveness.
- No. 2 in the world in the “Health Care: Pharmacy and Other Services” category for social responsibility and long-term investment.
- No. 5 globally in Innovation.
- No. 10 globally for People Management.
- Among the most admired companies in
New Jersey .
“Medco’s more than 20,000 employees are honored to earn a place on Fortune‘s list of the world’s most innovative companies. We are, however, even more gratified by the trust and confidence of our clients and their members as we continue to innovate around pharmacy practices that enable a new era of precision medicine — serving as a catalyst for healthcare reform in America,” continued Snow.
Medco is redefining the practice of pharmacy by training more than 1,000 of its specialist pharmacists to help improve the quality of care for patients with chronic and complex conditions — patients who account for 96 percent of drug spending and 75 percent of overall medical spending. These pharmacists are better positioned to identify safety issues and consult more effectively with doctors to improve clinical and financial outcomes. The specialist pharmacists work within Medco Therapeutic Resource Centers(R) located nationwide and focused on major conditions that include diabetes, oncology, arthritis, high blood pressure, high cholesterol and neurology/psychology.
Medco is focused on closing gaps in clinical care, improving patient health and lowering overall medical costs. This is accomplished by partnering with member advocacy programs to engage and educate consumers, pharmacogenomics research that helps physicians in the selection of the right medicine and dose based on a patient’s unique genetic make-up as well as other clinical initiatives.
About Medco
Medco Health Solutions, Inc. is a leading health care company, serving the needs of more than 60 million people. Medco, the world’s most advanced pharmacy(R), provides clinically driven pharmacy services designed to improve the quality of care and lower total health care costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. Through its unique Medco Therapeutic Resource Centers(R) and the Accredo Health Group, Medco’s Specialty Pharmacy, the company is creating innovative models for the care of patients with chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy — a key element in reforming America’s health care system. Medco is ranked number 51 on the Fortune 500 list, with 2008 revenues of more than
This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.
SOURCE Medco Health Solutions, Inc.